Allspring Global Investments Holdings, LLC Apellis Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 6,522 shares of APLS stock, worth $178,963. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,522
Previous 72,468
91.0%
Holding current value
$178,963
Previous $2.78 Million
93.23%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$427 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$326 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$305 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$269 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$159 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.01B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...